Literature DB >> 27358781

Impact of body mass index on outcomes of 48281 patients undergoing first time cadaveric liver transplantation.

Subhashini Ayloo1, Scott Hurton1, Matthew Cwinn1, Michele Molinari1.   

Abstract

AIM: To investigate possible disparities in perioperative morbidity and mortality among different body mass index (BMI) groups and to simulate the impact that these differences might have had on the cohort of patients undergoing cadaveric liver transplantation (LT).
METHODS: All adult recipients undergoing first time LT for benign conditions and receiving a whole graft from brain-dead donors were selected from the united network of organ sharing registry. From January 1994 to June 2013, 48281 patients satisfied the inclusion criteria and were stratified by their BMI. The hypothesis that abnormal BMIs were independent predictors of inferior outcomes was tested with univariate and multivariate regression analyses.
RESULTS: In comparison to normal weight recipients, underweight and morbidly obese recipients had increased 90-d mortality (adjusted OR = 1.737; 95%CI: 1.185-2.548, P = 0.005) (adjusted OR = 1.956; 95%CI: 1.473-2.597, P = 0.000) respectively and inferior patients' survivals (adjusted HR = 1.265; 95%CI: 1.096-1.461, P = 0.000) (adjusted HR = 1.157; 95%CI: 1.031-1.299, P = 0.013) respectively. Overall, patients' 5-year survival were 73.9% for normal-weight, 71.1% for underweight, 74.0% for overweight, 74.4% for class I obese, 75.0% for class II obese and 71.5% for class III obese recipients. Analysis of hypothetical exclusion of underweight and morbidly obese patients from the pool of potential LT candidates would have improved the overall survival of the entire cohort by 2.7% (95%CI: 2.5%-3.6%).
CONCLUSION: Selected morbidly obese patients undergoing LT for benign conditions had 5-year survival rates clinically comparable to normal weight recipients. Impact analysis showed that exclusion of high-risk recipients (underweight and morbid obese patients) would not significantly improve the overall survival of the entire cohort of patients requiring LT.

Entities:  

Keywords:  Body mass index; Impact analysis; Liver transplantation; Obesity; Survival

Year:  2016        PMID: 27358781      PMCID: PMC4919740          DOI: 10.5500/wjt.v6.i2.356

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  28 in total

1.  Impact of recipient morbid obesity on outcomes after liver transplantation.

Authors:  Ashish Singhal; Gregory C Wilson; Koffi Wima; R Cutler Quillin; Madison Cuffy; Nadeem Anwar; Tiffany E Kaiser; Flavio Paterno; Tayyab S Diwan; E Steve Woodle; Daniel E Abbott; Shimul A Shah
Journal:  Transpl Int       Date:  2015-02       Impact factor: 3.782

2.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

Review 3.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

4.  Who should get a liver graft?

Authors:  Richard B Freeman; Neville Jamieson; Douglas E Schaubel; Robert J Porte; Federico G Villamil
Journal:  J Hepatol       Date:  2009-02-12       Impact factor: 25.083

5.  Cox regression analysis of multivariate failure time data: the marginal approach.

Authors:  D Y Lin
Journal:  Stat Med       Date:  1994-11-15       Impact factor: 2.373

6.  Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

7.  Gender differences in liver donor quality are predictive of graft loss.

Authors:  J C Lai; S Feng; J P Roberts; N A Terrault
Journal:  Am J Transplant       Date:  2011-01-10       Impact factor: 8.086

8.  Obesity increases mortality in liver transplantation--the Danish experience.

Authors:  Jens G Hillingsø; André Wettergren; Masanobu Hyoudo; Preben Kirkegaard
Journal:  Transpl Int       Date:  2005-11       Impact factor: 3.782

9.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 10.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  1 in total

1.  Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations.

Authors:  Michele Molinari; Subhashini Ayloo; Allan Tsung; Dana Jorgensen; Amit Tevar; Sheikh Hasibur Rahman; Naudia Jonassaint
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.